The Effect of Exercise on Individuals With Parkinson's Disease
2 other identifiers
interventional
51
1 country
1
Brief Summary
The goal of this trial is to compare the effect of two different exercise programs on neuro-physiological, motor, functional, and quality-of-life issues in individuals with Parkinson's disease to determine which program is most beneficial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 26, 2007
CompletedFirst Posted
Study publicly available on registry
January 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedResults Posted
Study results publicly available
February 9, 2015
CompletedMarch 5, 2015
February 1, 2015
3.8 years
December 26, 2007
December 23, 2014
February 16, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Off Medication UPDRS Part III, Motor Subscale Score
UPDRS part III, is an observer rated clinical measure of motor signs of PD. It is used as a measure of severity of motor signs. We measured this at baseline, 6 , 18 and 24 months. This is a ordinal scale of 0-4 which has 27 items which measures slowness of movement (Bradykinesia), Tremor, Rigidity (muscle stiffness) and postural instabilty. The total value for UPDRS part III scale which ranges from 0 to 108, with a larger number indicating a higher level of impairment.
obtained during initial evaluation & then every 6 six months to end of 2-yr training period
Secondary Outcomes (34)
On Medication UPDRS-III
obtained during initial evaluation & then every 6 six months to end of 2-yr training period
L-dopa equivalent-mg/Day
obtained during initial evaluation & then every 6 six months to end of 2-yr training period
Elbow Flexion Strength
obtained during initial evaluation & then every 6 six months to end of 2-yr training period
Ankle Plantar Flexion Strength
obtained during initial evaluation & then every 6 six months to end of 2-yr training period
Elbow Extension Strength
obtained during initial evaluation & then every 6 six months to end of 2-yr training period
- +29 more secondary outcomes
Study Arms (2)
Progressive resistance training
ACTIVE COMPARATORSubjects will perform between 60 and 90 minutes of progressive resistance training two times a week for two years at a local gym. These sessions will be supervised by a personal trainer two times a week for the first six months of training and then once a week for the remaining 18 months of training.
Modified Fitness Counts
ACTIVE COMPARATORSubjects will perform between 60 and 90 minutes of modified Fitness Counts two times a week for two years at a local gym. These sessions will be supervised by a personal trainer two times a week for the first six months of training and then once a week for the remaining 18 months of training.
Interventions
Exercise twice a week for 2 years doing either progressive resistance training. The The PRE program consisted of 11 strengthening exercises: chest press, latissimus pull downs, reverse flys, double leg press, hip extension, shoulder press, biceps curl, rotary calf (ankle plantar flexion), triceps extension, seated quadriceps extension and back extension.
The modified Fitness Counts program was taken from Chapters 2 and 3 of the Parkinson's disease: Fitness Counts booklet and focused on non-progressive stretching, strengthening and balance exercises.
Eligibility Criteria
You may qualify if:
- a diagnosis of PD
- Up to the age of 67
- on at least 1 DA drug, may be on several PD medications
- able to walk for six minutes (may take rest breaks)
- able to come off their PD medication for testing (12 hour overnight withdrawal of antiparkinsonian medications)
- able to stay on stable PD medications for at least 6 months
- live within a 30 mile radius of Chicago
- Hoehn and Yahr Score: II - III while in the "Off" PD medication state
You may not qualify if:
- history of any other neurological disorder as determined by medical history and neurological exam
- history of a known injury, disease, or other disorder that might interfere with motor function in the proposed experiments
- a score less than 23 on the Mini-Mental State Examination
- currently involved in an active, ongoing formal exercise program deep brain stimulation surgery
- known cardiac problem or significant hypertension
- depression that may interfere with regular exercise
- hallucinations or being treated for hallucinations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Physical Therapy Department at the University of Illinois at Chicago
Chicago, Illinois, 60612, United States
Related Publications (3)
Ernst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
PMID: 38588457DERIVEDErnst M, Folkerts AK, Gollan R, Lieker E, Caro-Valenzuela J, Adams A, Cryns N, Monsef I, Dresen A, Roheger M, Eggers C, Skoetz N, Kalbe E. Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
PMID: 36602886DERIVEDDavid FJ, Robichaud JA, Leurgans SE, Poon C, Kohrt WM, Goldman JG, Comella CL, Vaillancourt DE, Corcos DM. Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial. Mov Disord. 2015 Oct;30(12):1657-63. doi: 10.1002/mds.26291. Epub 2015 Jul 6.
PMID: 26148003DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Daniel Corcos, PhD
- Organization
- Northwestern University
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel Corcos, Ph.D.
Northwestern University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 26, 2007
First Posted
January 11, 2008
Study Start
October 1, 2007
Primary Completion
July 1, 2011
Study Completion
October 1, 2011
Last Updated
March 5, 2015
Results First Posted
February 9, 2015
Record last verified: 2015-02